SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Short Candidates
An SI Board Since December 2000
Posts SubjectMarks Bans
897 95 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
672You do not waste time! [eom]Miljenko Zuanic-5/27/2004
671Shorting half position of EYET at the current bid, $40.90. Cheers, Tucktuck-5/27/2004
670Removing GNTA as too dead for action, and putting in EYET, which has also been stuck-5/26/2004
669Project Bio-shield was signed and came as a jolt to the market. Hollis' immkeokalani'nui-5/25/2004
668>>Hey tuck, how about a quick short of hollis-eden, the company apparentlytuck-5/25/2004
667">>10:33AM Onyx Pharma target raised to $66 from $40 at JMP (ONXX) 56Miljenko Zuanic-5/20/2004
666Hey tuck, how about a quick short of hollis-eden, the company apparently with a keokalani'nui-5/19/2004
665I have no idea who this firm is, but from Barron's: Pozen (POZN-NYSE) by M.mopgcw-5/11/2004
664Tuck, I am terrible in timing any short or long for that case. Lately, I am terMiljenko Zuanic-5/10/2004
663They'll probably try to make something of their results to date at ASCO. Astuck-5/10/2004
662Stock and few analysts are acting like open/randomized-blind PII in CRC will be Miljenko Zuanic-5/6/2004
661I stand somewhat corrected. NKTR/PFE have done extension studies to study the atuck-5/6/2004
660Some links to Bay 43-9006 data: kidneycancertrials.org onyx-pharm.com "Ptuck-5/6/2004
659I liked the part about: "stronger than expected Q1 results" and "rkrw-5/6/2004
658>>>ONXX<<<< If you ask me...bay-whatever molecule they arezeta1961-5/6/2004
657An analyst catches up to the market, and tries to get in front . . . >&tuck-5/6/2004
656NKTR looked at both, but not for 12 months. Type 1 six months, Type 2 three montuck-5/5/2004
655Starting here with a half position of ONXX again, 200 shares at $55.70. Cheers,tuck-5/5/2004
654Tuck, I agree that the ARDM results do pose a challenge to NKTR, and so the NKTBiomaven-5/5/2004
653Per my posting on the Diabetes thread, I now include NKTR on the WatchList, and tuck-5/5/2004
652My goodness, I hadn't noticed that Hemispherx (HEB) had actually gotten abovtuck-4/30/2004
651nice job. (eom)scaram(o)uche-4/28/2004
650Target for ONXX was $51, which was hit. BSCP takes its little profit there and tuck-4/28/2004
649Tuck, fwiw (probably not much), but a trader who haunts SI, traditionally tech quidditch-4/26/2004
648FBR's target came in range this morning as Tarceva results lifted any stock tuck-4/26/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News